Product Categories
| Country: | China |
|---|---|
| Tel: | 021-65675885 |
| Mobile: | 18964387627 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| C12 NBD Galactosylceramide (d18:1/6:0) | C42H71N5O11 | 474942-98-8 | Details |
| 11-deoxy Prostaglandin F2β | C20H34O4 | 37786-07-5 | Details |
| 15-keto Prostaglandin F2α | C20H32O5 | 35850-13-6 | Details |
| Lalistat 1 | C12H18N4O3S | 501104-16-1 | Details |
| 13(E)-Docosenoic Acid | C22H42O2 | 506-33-2 | Details |
| 5-trans Prostaglandin F2β | C20H34O5 | 36150-02-4 | Details |
| 18-methyl Eicosanoic Acid | C21H42O2 | 36332-93-1 | Details |
| Linoelaidic Acid | C18H32O2 | 506-21-8 | Details |
| Palmitoleoyl Chloride | C16H29ClO | 40426-22-0 | Details |
| Bupivacaine-d9 | C18H28N2O | 474668-57-0 | Details |
| 20-ethyl Prostaglandin F2α | C22H38O5 | 36950-85-3 | Details |
| Prostaglandin B3 | C20H28O4 | 36614-32-1 | Details |
| BCATc Inhibitor 2 | C16H10ClF3N2O4S | 406191-34-2 | Details |
| 15(R)-Prostaglandin E2 | C20H32O5 | 38873-82-4 | Details |
| DL-erythro/threo Sphinganine (d16:0) | C16H35NO2 | 50731-08-3 | Details |
| 16-hydroxy Hexadecanoic Acid | C16H32O3 | 506-13-8 | Details |
| Tris(4,7-diphenyl-1,10-phenanthroline)ruthenium II dichloride complex | C72H48Cl2N6Ru | 36309-88-3 | Details |
| Glucotropaeolin (potassium salt) | C14H18KNO9S2 | 5115-71-9 | Details |
| 13,14-dihydro-15-keto Prostaglandin F2α-d4 | C20H34O5 | 42932-59-2 | Details |
| 17-phenyl trinor Prostaglandin A2 | C23H28O4 | 38315-51-4 | Details |
| C12 NBD L-threo dihydro Ceramide (d18:0/12:0) | C36H63N5O6 | 474943-07-2 | Details |
| 11-deoxy Prostaglandin F2α | C20H34O4 | 37786-06-4 | Details |
| 16,16-dimethyl Prostaglandin A2 | C22H34O4 | 41691-92-3 | Details |
| 2-methyl Benzamideoxime | C8H10N2O | 40312-14-9 | Details |
| 20-ethyl Prostaglandin E2 | C22H36O5 | 37492-24-3 | Details |
| (+)-3-Carene | C10H16 | 498-15-7 | Details |
| Vacuolin-1 | C26H24IN7O | 351986-85-1 | Details |
| MJN228 | C20H20N4O3 | 459168-97-9 | Details |
| SI-2 | C15H15N5 | 380537-35-9 | Details |
| NSC 185058 | C11H9N3S | 39122-38-8 | Details |
| MST312 | C20H16N2O6 | 368449-04-1 | Details |
| Butenoyl PAF | C28H56NO7P | 474944-25-7 | Details |
| (S)-Bromoenol lactone | C16H13BrO2 | 478288-94-7 | Details |
| D-NAME (hydrochloride) | C7H16ClN5O4 | 50912-92-0 | Details |
| β-D-Glucose | C6H12O6 | 492-61-5 | Details |
| Biphenyl-4-amidoxime | C13H12N2O | 40019-44-1 | Details |
| cis-9,10-Methyleneoctadecanoic Acid | C19H36O2 | 4675-61-0 | Details |
| 15(S)-15-methyl Prostaglandin E2 | C21H34O5 | 35700-27-7 | Details |
| β-Defensin-4 (human) (trifluoroacetate salt) | C182H296F3N63O54S6 | 370570-43-7 | Details |
| Acetylaszonalenin | C25H25N3O3 | 42230-55-7 | Details |
| Monogalactosyl Diglyceride | C45H86O10 | 41670-62-6 | Details |
| Linoleic Acid Amide | C18H33NO | Details |
| SSR 240612 | C42H53ClN4O7S | 464930-42-5 | Details |
| C8 Galactosylceramide (d18:1/8:0) | C32H61NO8 | 41613-16-5 | Details |
| Glucagon Receptor Antagonist Inactive Control | C21H23BrN2OS | 362482-00-6 | Details |
| N,N-dimethyl Sphingosine (d17:1) | C19H39NO2 | 474943-92-5 | Details |
| 27-hydroxy Heptacosanoic Acid methyl ester | C28H56O3 | 369635-50-7 | Details |
| Cyclo(L-Phe-L-Val) | C14H18N2O2 | 35590-86-4 | Details |
| Amiprofos-methyl | C11H17N2O4PS | 36001-88-4 | Details |
| 4-deoxy-4α-Phorbol | C20H28O5 | 37415-57-9 | Details |
| Sphingomyelins (egg) | C39H79N2O6P | 383907-87-7 | Details |
| 3-Pyrimidin-2-yl-Propionic Acid | C7H8N2O2 | 439108-20-0 | Details |
| Carboxyatractyloside (potassium salt) | C31H46O18S2 | 35988-42-2 | Details |
| Methylcardol triene | C22H32O2 | 50423-15-9 | Details |
| 5-trans Prostaglandin E2 | C20H32O5 | 36150-00-2 | Details |
| Butaprost (free acid) | C23H38O5 | 433219-55-7 | Details |
| CCK (27-33) (non-sulfated) | C45H57N9O10S2 | 47910-79-2 | Details |
| Prostaglandin A3 | C20H28O4 | 36614-31-0 | Details |
| 11-deoxy Prostaglandin F1α | C20H36O4 | 37785-98-1 | Details |
| Brevianamide F | C16H17N3O2 | 38136-70-8 | Details |
| 9(Z),11(E),13(E)-Octadecatrienoic Acid ethyl ester | C20H34O2 | 42021-86-3 | Details |
| Pentacosanoic Acid | C25H50O2 | 506-38-7 | Details |
| C6 NBD Lactosylceramide (d18:1/6:0) | C42H69N5O16 | 474943-04-9 | Details |
| C12 Galactosylceramide (d18:1/12:0) | C36H69NO8 | 41613-14-3 | Details |
| Todralazine (hydrochloride) | C11H13ClN4O2 | 3778-76-5 | Details |
| cis-Vaccenic Acid | C18H34O2 | 506-17-2 | Details |
| KIN1400 | C24H17F2N3O2S | 446826-86-4 | Details |
| PSB-1115 (potassium salt) | C14H15KN4O5S | 409344-71-4 | Details |
| C12 NBD Lactosylceramide (d18:1/12:0) | C48H81N5O16 | 474943-06-1 | Details |
| (R)-Bromoenol lactone | C16H13BrO2 | 478288-90-3 | Details |
| Cardanol monoene | C21H34O | 501-26-8 | Details |
| 9-Amino-6-chloro-2-methoxyacridine | C14H11ClN2O | 3548-09-2 | Details |
| 3-methyl Orsellinic Acid | C9H10O4 | 4707-46-4 | Details |
| Urocortin II (human) (trifluoroacetate salt) | C196H340F3N63O56S | 398001-88-2 | Details |
| C30(ω-hydroxy) Ceramide (d18:1/30:0) | C48H95NO4 | 457100-08-2 | Details |
| 4-carboxy TEMPO | C10H18NO3* | 37149-18-1 | Details |
| L-Canaline | C4H10N2O3 | 496-93-5 | Details |
| 5-trans Prostaglandin F2α | C20H34O5 | 36150-01-3 | Details |
| 5-(2-Aminopyridyl)amide oxime | C6H8N4O | 468068-28-2 | Details |
| 15(R)-15-methyl Prostaglandin F2α methyl ester | C22H38O5 | 35700-22-2 | Details |
| Pyrazine-2-amidoxime | C5H6N4O | 51285-05-3 | Details |
| 10074-G5 | C18H12N4O3 | 413611-93-5 | Details |
| 11β-Prostaglandin F1β | C20H36O5 | 37785-86-7 | Details |
| 11-deoxy Prostaglandin F1β | C20H36O4 | 37785-99-2 | Details |
| 20-hydroxy Arachidic Acid methyl ester | C21H42O3 | 37477-29-5 | Details |
| 15(R)-Prostaglandin F2α | C20H34O5 | 37658-84-7 | Details |
| Galactosylcerebrosides (hydroxy) | C44H89NO5 | 37211-11-3 | Details |
| Product Total： Product Page： | ||||
| 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 | ||||